title: Agranulocytosis, plasmacytosis, and thrombocytosis due to methimazole-induced bone marrow toxicity.
authors.forename: Eun-Jee
authors.initials: EJ
authors.lastname: Oh
authors.forename: Hyo-Jin
authors.initials: HJ
authors.lastname: Chae
authors.forename: Yeon-Joon
authors.initials: YJ
authors.lastname: Park
authors.forename: Jong-Won
authors.initials: JW
authors.lastname: Park
authors.forename: Kyungja
authors.initials: K
authors.lastname: Han
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced* / Q000188:drug therapy; D001853:Bone Marrow / Q000187:drug effects* / Q000473:pathology; D005500:Follow-Up Studies; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006111:Graves Disease / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D008297:Male; D008713:Methimazole / Q000009:adverse effects* / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D010950:Plasma Cells / Q000187:drug effects* / Q000473:pathology; D013922:Thrombocytosis / Q000139:chemically induced* / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D016179:Granulocyte Colony-Stimulating Factor; D008713:Methimazole; D008775:Methylprednisolone